ACAPELLA: Real-World Experience with Ocrelizumab: An Observational Study Evaluating Safety in Patients with Relapsing and Progressive MS, Late Breaking Data
MULTIPLE SCLEROSIS JOURNAL(2022)
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要
MULTIPLE SCLEROSIS JOURNAL(2022)